Recent research suggests a link between vitamin K intake and the development of some types of cancer. In a Danish study of more than 56,000 men, higher intakes of vitamin K1 were associated with lower rates of cancer-related death. Additionally, a US study showed that vitamin K1 intake may reduce the risk of pancreatic cancer.
On the other hand, laboratory studies have shown that vitamin K2 may slow the progression of prostate cancer in mice. Research also suggests that vitamin K2 may enhance the effects of some chemotherapy treatments, making it a potential adjuvant in cancer treatment.
However, it should be noted that these findings are still in their early stages, and more clinical studies are needed to determine the potential benefits of vitamin K intake in preventing or treating cancer. Therefore, it is advisable to consult a healthcare professional before starting any dietary supplement regimen.
Leave a Reply